Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: Role of phosphatidylinositol 3-kinase Akt pathway

Transplantation

Volumn 84, Issue 3, 2007, Pages 380-386

  Gao, Ling ^a   Kwan, Jair C ^a   Macdonald, Peter S ^a,b   Yang, Lianxing ^a   Preiss, Thomas ^a,c   Hicks, Mark ^a,b,d  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ST VINCENT'S CLINIC   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Donor heart preservation; Ischemia reperfusion; PARP inhibition; PI3 kinase Akt; Transplantation

Indexed keywords

CELSIOR; INO 1153; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CRYOPRESERVATION; ENZYME INHIBITION; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART OUTPUT; HEART PROTECTION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; DISACCHARIDES; ELECTROLYTES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATES; GLUTATHIONE; HEART; HEART TRANSPLANTATION; HISTIDINE; MALE; MANNITOL; MODELS, ANIMAL; MYOCARDIUM; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 34547862049     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000276924.08343.78     Document Type: Article

References (45)

1. Hosenpud JD, Bennett LE, Keck BM, et al. The registry of the International Society for Heart and Lung Transplantation: Eighteenth official report - 2001. J Heart Lung Transplantant 2001; 20: 805.
2. Hicks M, Hing A, Gao L, et al. Organ preservation. Meth Mol Biol 2006; 333: 331.
3. Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181.
4. Szabo G, Liaudet L, Hagl S, Szabo S. Poly (ADP-ribose) activation in the reperfused myocardium. Cardiovasc Res 2004; 61: 471.
5. +. FEBS J 2005; 272: 4576.
6. Yu SW, Wang H, Poitras MF, et al. Mediation of poly(ADP-ribose) polymerase dependent cell death by apoptosis inducing factor. Science 2002; 297: 259.
7. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375.
8. Zingarelli B, Salzman AL, Szabo C. Genetic disruption of poly(ADP-ribose) polymerase inhibits expression of P-selectin and intracellular adhesion molecule - 1 in myocardial ischemia reperfusion injury. Circ Res 1998; 83: 85.
9. Grupp IL, Jackson TM, Hake P, et al. Protection against hypoxia - reoxygenation in the absence of poly(ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol 1999; 31: 297.
10. Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3: 1089.
11. Liaudet L, Pacher P, Mabley JG, et al. Activation of poly(ADP-ribose) polymerase 1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372.
12. Olivier FJ, Menissier de Murcia J, Nacci C, et al. Resistance to endotoxic shock as a consequence of defective NF-kB activation in poly(ADP-ribose) polymerase 1 deficient mice. EMBO J 1999; 18: 4446.
13. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Disc 2005; 4: 421.
14. Yamazaki K, Miwa S, Ueda K, et al. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: In vitro study of isolated rat heart model. Eur J Cardiothorac Surg 2004; 26: 270.
15. Pacher P, Vaslin A, Benko R, et al. A new potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther 2004; 311: 485.
16. Khan TA, Ruel M, Bianchi C, et al. Poly (ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia cardiopulmonary bypass. J Am Coll Surg 2003; 197: 270.
17. Szabo G, Bahrle S, Stumpf N, et al. Contractile dysfunction in experimental cardiac allograft rejection: Role of the poly (ADP-ribose) polymerase pathway. Transpl Int 2006; 19: 506.
18. Szabo G, Soos P, Heger U, et al. Poly (ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation. Eur J Cardiothorac Surg 2005; 27: 226.
19. Veres B, Gallyas F, Varbiro G, et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly (ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003; 65: 1373.
20. Tapodi A, Debreceni B, Hanto K, et al. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase 1 inhibition in oxidative stress. J Biol Chem 2005; 280: 35767.
21. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischemia - reperfusion injury: Targeting the reperfusion injury salvage kinase (RISK) pathway. Cardiovasc Res 2004; 61: 448.
22. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005; 15: 69.
23. Gao L, Hicks M, Macdonald PS. Improved preservation of the rat heart with Celsior solution supplemented with cariporide plus glyceryl trinitrate. Am J Transplant 2005; 5: 1820.
24. + inhibition and ATP-sensitive potassium channel activation. J Heart Lung Transplant 2003; 22: 1245.
25. Southan GJ, Szabo C. Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 2003; 10: 321.
26. Palfi A, Toth A, Kulcsar G, et al. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langenforff perfused and in isoproterenol-damaged rat hearts. J Pharmacol Exp Ther 2005; 315: 273.
27. Kovacs K, Toth A, Deres P, et al. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia reperfusion. Biochem Pharmacol 2006; 71: 441.
28. Fariver AS, McCourtie AS, MacKinnon-Patterson BC, et al. Poly(ADP-ribose) polymerase inhibition improves rat cardiac allograft survival. Ann Thorac Surg 2005; 80: 950.
29. Szabo G, Bahrle S, Sivanandam V, et al. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection. J Heart Lung Transplant 2006; 25: 794.
30. Mangino MJ, Ametani M, Szabo C, Southard JH. Poly(ADP-ribose) polymerase and renal hypothermic preservation injury. Am J Physiol Renal Physiol 2004; 286: F838.
31. Feron O, Belhassen L, Kobzik L, et al. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271: 22801.
32. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601.
33. Du ZY, Hicks M, Janz P, et al. The nitric oxide donor, diethylamine NONOate enhances preservation of the donor heart. J Heart Lung Transplant 1998; 17: 1113.
34. 2+ storage. Cardiovasc Res 2006; 70: 346.
35. Cittadini A, Monti MG, Iaccarino G, et al. Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. Gene Ther 2006; 13: 8.
36. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231.
37. Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 2001; 98: 11598.
38. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857.
39. Madrid LV, Wang CY, Guttridge DC, et al. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p56 subunit of NF-κB. Mol Cell Biol 2000; 20: 1626.
40. Chu ZL, McKinsey TA, Liu L, et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA 1997; 94: 10057.
41. Stehlik C, de Martin R, Kumabashiri I, et al. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1998; 188: 211.
42. Catz SD, Johnson JL. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 2001; 20: 7342.
43. Chen F, Sun S, Kuhn DC, et al. Involvement of NF-kappaB in silica-induced cyclooxygenase II gene expression in rat alveolar macrophages. Am J Physiol 1997; 272: L779.
44. Lee HH, Dadgostar H, Cheng Q, et al. NF-kappaB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 1999; 96: 9136.
45. Piper HM, Kasseckert S, Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res 2006; 70: 170.